BSEM stock Statistics — BioStem Technologies, Inc. filings, insiders & smart money

Price and daily changeSign in

Earnings12 Nov 2026

52-week rangeSign inDay rangeSign in

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-08-12 · filed common shares: 17.84M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 19.66%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.67%
Short ratioDays to cover, as published by FINRA: 1.34
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 48.80%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 46.40%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross margin (quarter)Quarter: 2026-04-01 to 2026-06-30 · Not annualized: 61.28%
Operating margin (quarter)Quarter: 2026-04-01 to 2026-06-30 · Not annualized: -106.35%
Net margin: —
EBITDA margin (quarter)Quarter: 2026-04-01 to 2026-06-30 · Not annualized: -97.62%
Return on equity: —
Return on assets: —

Sign in

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPS (diluted, quarter)Quarter: 2026-04-01 to 2026-06-30 · Not annualized

-0.52

EPS (fwd)

Cash & equivalentsas of Jun 26: $6.96M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $223.82K
Debt / equityas of Jun 26: 0.81%
Current ratioas of Jun 26: 0.98
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 0.64
Operating cash flow (six months)Six months: 2026-01-01 to 2026-06-30 · Not annualized: -$6.36M
Free cash flow (six months)Six months: 2026-01-01 to 2026-06-30 · Not annualized: -$6.42M
TTM revenue / diluted share: —